Lingraphica develops augmentative and alternative communications (AAC) technology -- notably speech generating devices.

Its two main products, the AllTalk and the TouchTalk, are designed to help persons with aphasia -- and other neural disorders affecting language -- to recover the ability to communicate with others.

The devices provide synthetic speech and an expandable, symbols-based vocabulary from which users select the words and phrases they need to express thoughts.